Antabio is a clinical-stage biopharmaceutical company developing novel antibacterial treatments targeting drug-resistant infections identified by WHO and CDC as critical priorities, focusing on life-threatening hospital infections
Antabio is a clinical-stage biopharmaceutical company developing novel antibacterial treatments targeting drug-resistant infections identified by WHO and CDC as critical priorities, focusing on life-threatening hospital infections.